Business Context and Reporting Period
This Form 6-K filing by Fresenius Medical Care AG & Co. KGaA covers the month of December 2012, specifically dated December 10, 2012. The report serves to disclose a corporate governance update regarding the appointment of a new executive officer to the Management Board.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a notification of a personnel change and does not contain financial statements or performance data.
Material Changes
The material change disclosed is the appointment of a new Chief Officer of Global Research and Development (R&D), who will also serve as a member of the Management Board. No financial or operational changes were reported in this specific filing.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, risks, contingencies, or unusual items. The content is limited to the announcement of the executive appointment.
Investor Verification Checklist
- Verify the full name and background of the newly appointed Chief Officer of Global R&D.
- Confirm the effective date of the appointment as detailed in the referenced Investor News Release (Exhibit 99.1).
- Review subsequent filings for any impact this leadership change may have on the company's R&D strategy or financial outlook.